Gen-Probe Receives FDA Clearance to Test Additional Specimen Types for STDs With the APTIMA Combo 2(R) Assay on the (Women's Cancer Network)
Genetic Engineering News; Yahoo! News SAN DIEGO, Aug. 22 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing clearance to use the APTIMA Combo 2(R) assay to test two additional kinds of patient samples for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) on the fully automated TIGRIS(R) system.

NovaDel Announces FDA Acceptance of Zensana(TM) NDA For Review (RedNova)
NovaDel Pharma (AMEX: NVD) today announced that

US FDA approves generic version of injectable cipro (PharmaBiz)
The Food and Drug Administration (FDA) approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corporation Pharmaceutical Division's Cipro I.V., a drug to treat certain bacterial infections.